Dartmouth SYNERGY Clinical and Translational Science Institute (CTSI) announced the appointment of four physician-investigators to the 2019 Clinical Research Fellowship program, a mechanism to support and nurture Dartmouth-Hitchcock clinicians who have a passion to develop their research careers. The awardees are: Lesley Jarvis, MD, PhD; Meredith MacMartin, MD, MS; Nathaniel Robbins, MD; and Michael Young, MD.
Articles by: Geisel Communications
Weighing the Dangers of Cannabis – Nature
Read article – Quotes Alan Budney, professor of psychiatry, in an article about a recent study that examines the risks of cannabis as claims of the drug’s health benefits become increasingly common.
The Last of the Last of Noda Farm’s Blueberries – Valley News
Read article – An article about the closing of Mediden, N.H., Noda Farm, which mentions that the farm was started by former Dartmouth medical school professor Lafayette Noda, who continued running the business until he was 92.
Dartmouth Doctor Reiterates Risks of E-Cigarettes for Youths – Valley News
Read article – Features comments by Susanne Tanski, associate professor of pediatrics, about safety concerns regarding e-cigarette devices in the wake of the first known death resulting from severe lung disease in those who use e-cigarette devices. “Our young people need to understand that these are not safe products,” said Tanski.
Link Explored Between Blue-Green Algae and ALS – VT Digger
Read article – Quotes Elijah Stommel, professor of neurology, in an article that examines the connection between ALS and blue-green algae blooms. Stommel has participated in a number of studies researching whether there is a link between the cyanobacteria released by blue-green algae and ALS. “About 10 years ago, we were mapping out occurrences of ALS and found clustering around lakes that had lots of algal blooms,” said Stommel.
Meaningful PTSD Symptom Decrease May Lower Type 2 Diabetes Risk – Health News Digest
Read article – An article that mentions that Paula Schnurr, professor of psychiatry, contributed to research from Saint Louis University that found that treatment for Post-Traumatic Stress Disorder (PTSD) leading to an improvement in symptoms was associated with a 49% lower risk of incident type 2 diabetes.
Growth Prospects for Vertebrobasilar Insufficiency Treatment Market Reflect Increasing Awareness About Health & Wellness 2018 to 2028 – Westminster News Online
Read article – Cites data conducted by researchers at the Geisel School of Medicine that found that approximately 700,000 adults in the U.S. have a stroke and 80% of all strokes are ischemic.
Trial Finds Winning Antibiotic for Bronchiectasis in Kids – MedPage Today
Read article – Quotes Brian O’Sullivan, professor of pediatrics, from an editorial he published to accompany a report on the results of a the BEST-1study—which the editorial called “a three-arm, double-dummy, randomized placebo-controlled trial of amoxicillin–clavulanate or azithromycin versus placebo.” (O’Sillivan’s editorial was published in The Lancet.)
Brand-name Drug Prices Rising at Slower Pace, Lower Amounts – Associated Press
Read article – Quotes Adrienne Faerber, lecturer for The Dartmouth Institute for Health Policy and Clinical Practice, in an article about a study that found that drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to. (Picked up by CNBC, NBC News, ABC News, The New York Times, The Washington Post, Business Insider, Vindy, and many more.)
Brand-name Drug Prices Rising at Slower Pace, Lower Amounts – U.S. News & World Report via Associated Press
Read article – Continued coverage of comments by Adrienne Faerber, lecturer for The Dartmouth Institute for Health Policy and Clinical Practice, in an article about a study that found that drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to.
